Genetics and biology of prostate cancer

G Wang, D Zhao, DJ Spring… - Genes & …, 2018 - genesdev.cshlp.org
Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer
remains largely incurable even after intensive multimodal therapy. The lethality of advanced …

Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location

HE Taitt - American journal of men's health, 2018 - journals.sagepub.com
Although research has reported that prostate cancer (PCa) incidence and mortality rates are
among the highest for African Americans, the data is inconclusive regarding PCa rates in …

Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022 - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised …

U Menon, A Gentry-Maharaj, M Burnell, N Singh… - The Lancet, 2021 - thelancet.com
Background Ovarian cancer continues to have a poor prognosis with the majority of women
diagnosed with advanced disease. Therefore, we undertook the UK Collaborative Trial of …

The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance …

L Emmett, J Buteau, N Papa, D Moon, J Thompson… - European urology, 2021 - Elsevier
Background Multiparametric magnetic resonance imaging (MRI) is validated for the
detection of clinically significant prostate cancer (csPCa), although patients with …

Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening

JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

J Hugosson, MJ Roobol, M Månsson, TLJ Tammela… - European urology, 2019 - Elsevier
Abstract Background The European Randomized study of Screening for Prostate Cancer
(ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening …

10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer

FC Hamdy, JL Donovan, JA Lane… - … England Journal of …, 2016 - Mass Medical Soc
Background The comparative effectiveness of treatments for prostate cancer that is detected
by prostate-specific antigen (PSA) testing remains uncertain. Methods We compared active …

Global cancer incidence and mortality rates and trends—an update

LA Torre, RL Siegel, EM Ward, A Jemal - Cancer epidemiology, biomarkers & …, 2016 - AACR
There are limited published data on recent cancer incidence and mortality trends worldwide.
We used the International Agency for Research on Cancer's CANCER Mondial …

Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence

AB Chinen, CM Guan, JR Ferrer, SN Barnaby… - Chemical …, 2015 - ACS Publications
Cancer is the second most common cause of death in the United States, trailing only heart
disease in incidence. Despite significant worldwide investment in research, cancer remains …